No abstract available
Keywords:
Adakveo; Droxia; Endari; Hydrea; L-glutamine; Oxbryta; Siklos; adverse effects; crizanlizumab; dosage; drug interactions; efficacy; hydroxyurea; lactation; pregnancy; safety; sickle cell disease; voxelotor.
MeSH terms
-
Anemia, Sickle Cell / drug therapy*
-
Anemia, Sickle Cell / physiopathology
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antisickling Agents / adverse effects
-
Antisickling Agents / pharmacology
-
Antisickling Agents / therapeutic use*
-
Benzaldehydes / adverse effects
-
Benzaldehydes / pharmacology
-
Benzaldehydes / therapeutic use*
-
Hematologic Agents / adverse effects
-
Hematologic Agents / pharmacology
-
Hematologic Agents / therapeutic use
-
Humans
-
Pyrazines / adverse effects
-
Pyrazines / pharmacology
-
Pyrazines / therapeutic use*
-
Pyrazoles / adverse effects
-
Pyrazoles / pharmacology
-
Pyrazoles / therapeutic use*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antisickling Agents
-
Benzaldehydes
-
Hematologic Agents
-
Pyrazines
-
Pyrazoles
-
voxelotor
-
crizanlizumab